Categories: News

Sheaffer Pens Love Letter to Fans with New Emily in Paris Collection

Iconic Pen Brand Partners with Hit Series to Bring Parisian Elegance to Every Written Word

- Advertisement -

BANGALORE, India, Nov. 11, 2025 /PRNewswire/ — Sheaffer, the legendary American writing instruments brand synonymous with timeless innovation and craftsmanship, announced a collaboration with Paramount Consumer Products for Netflix’s beloved series, Emily in Paris, produced by Paramount Television Studios and creator Darren Star. Launching this holiday season, the limited-edition collection captures the romantic spirit of Paris and Emily Cooper’s ambitious charm through exquisitely designed writing instruments, notebooks, and leather accessories.

- Advertisement -

The Sheaffer x Emily in Paris collection invites fans to channel their inner Emily Cooper with beautifully crafted products that celebrate the art of thoughtful communication. From fountain pens perfect for penning postcards from Paris to journals ideal for capturing everyday adventures, each piece embodies the show’s sophisticated aesthetic and joie de vivre.

- Advertisement -

Emily in Paris celebrates connection, creativity, and the power of words; values that have been at the heart of Sheaffer for over a century,” said Nikhil Ranjan, CEO – Sheaffer. “This collaboration allows us to merge our heritage of fine writing with the show’s modern, fashion-forward spirit. We are giving fans the tools to write their own Parisian love story, one elegant stroke at a time.”

- Advertisement -

The collection features writing instruments adorned with Parisian motifs, notebooks with illustrated details inspired by Emily’s adventures, and sophisticated leather accessories including key fob wallets and passport cases. The design palette mirrors the show’s bold energy with pops of pink, classic black accents, and elegant gold hardware, quintessentially Emily.

- Advertisement -

The Sheaffer x Emily in Paris collection will be available from mid-November at select retailers world-wide and online at Sheaffer.com.

- Advertisement -

ABOUT SHEAFFER

- Advertisement -

For over a century, Sheaffer has stood as a symbol of refined craftsmanship and timeless luxury. Celebrated by connoisseurs worldwide, each Sheaffer pen unites heritage artistry with modern sophistication, an emblem of confidence, creativity, and distinction. From the hands of visionaries to collectors’ showcases, Sheaffer transforms writing into an experience of prestige and purpose. In an age of fleeting digital impressions, Sheaffer endures as the mark of permanence, a global icon where innovation meets legacy, and every line becomes a lasting expression of elegance.

- Advertisement -

Facebook | Instagram | Youtube

- Advertisement -

Photo: https://mma.prnewswire.com/media/2812861/Sheaffer_Emily_in_Paris.jpg
Logo: https://mma.prnewswire.com/media/2812860/Sheaffer_and_Emily_in_Paris_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/sheaffer-pens-love-letter-to-fans-with-new-emily-in-paris-collection-302611071.html

- Advertisement -

Recent Posts

More Than 60 Nations Unite as IIHM Launches GAIHEC, the World’s First Global AI Hospitality Education Council

On World AI Day, IIHM unveils a global movement to ensure Artificial Intelligence strengthens hospitality's…

3 hours ago

Singtel Receives Four Frost & Sullivan 2026 Recognitions for Leadership in Enterprise Connectivity, Cybersecurity, and Digital Transformation

The recognitions highlight Singtel's leadership in secure connectivity, network transformation, IoT innovation, and cybersecurity, delivering…

17 hours ago

4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population

July 18, 2026 15:15 ET  | Source: 4D Molecular Therapeutics, Inc. After a single intravitreal…

18 hours ago

Immuneering Corporation Announces Grants of Inducement Awards

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical…

18 hours ago

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

Silver Spring, MD, July 17, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration approved Lipfendra…

18 hours ago